Literature DB >> 2555787

RNase H cleavage of RNA hybridized to oligonucleotides containing methylphosphonate, phosphorothioate and phosphodiester bonds.

P J Furdon1, Z Dominski, R Kole.   

Abstract

Three types of 14-mer oligonucleotides were hybridized to human beta-globin pre-mRNA and the resultant duplexes were tested for susceptibility to cleavage by RNase H from E. coli or from HeLa cell nuclear extract. The oligonucleotides contained normal deoxynucleotides, phosphorothioate analogs alternating with normal deoxynucleotides, or one to six methylphosphonate deoxynucleosides. Duplexes formed with deoxyoligonucleotides or phosphorothioate analogs were susceptible to cleavage by RNase H from both sources, whereas a duplex formed with an oligonucleotide containing six methylphosphonate deoxynucleosides alternating with normal deoxynucleotides was resistant. Susceptibility to cleavage by RNase H increased parallel to a reduction in the number of methylphosphonate residues in the oligonucleotide. Stability of the oligonucleotides in the nuclear extract from HeLa cells was also tested. Whereas deoxyoligonucleotides were rapidly degraded, oligonucleotides containing alternating methylphosphonate residues remained unchanged after 70 minutes of incubation. Other oligonucleotides exhibited intermediate stability.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555787      PMCID: PMC335124          DOI: 10.1093/nar/17.22.9193

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  34 in total

1.  Rate of degradation of [alpha]- and [beta]-oligodeoxynucleotides in Xenopus oocytes. Implications for anti-messenger strategies.

Authors:  C Cazenave; M Chevrier; T T Nguyen; C Hélène
Journal:  Nucleic Acids Res       Date:  1987-12-23       Impact factor: 16.971

2.  Excess antisense RNA from infectious recombinant SV40 fails to inhibit expression of a transfected, interferon-inducible gene.

Authors:  S M Kerr; G R Stark; I M Kerr
Journal:  Eur J Biochem       Date:  1988-07-15

3.  Antisense DNA and RNA: progress and prospects.

Authors:  J Walder
Journal:  Genes Dev       Date:  1988-05       Impact factor: 11.361

4.  Role of RNase H in hybrid-arrested translation by antisense oligonucleotides.

Authors:  R Y Walder; J A Walder
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

Review 5.  Oligodeoxynucleotides as inhibitors of gene expression: a review.

Authors:  C A Stein; J S Cohen
Journal:  Cancer Res       Date:  1988-05-15       Impact factor: 12.701

6.  Inhibition of human immunodeficiency virus by using an oligonucleoside methylphosphonate targeted to the tat-3 gene.

Authors:  J A Zaia; J J Rossi; G J Murakawa; P A Spallone; D A Stephens; B E Kaplan; R Eritja; R B Wallace; E M Cantin
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

7.  Evaluation of N-ras oncogene anti-sense, sense and nonsense sequence methylphosphonate oligonucleotide analogues.

Authors:  D M Tidd; P Hawley; H M Warenius; I Gibson
Journal:  Anticancer Drug Des       Date:  1988-08

8.  Comparative hybrid arrest by tandem antisense oligodeoxyribonucleotides or oligodeoxyribonucleoside methylphosphonates in a cell-free system.

Authors:  L J Maher; B J Dolnick
Journal:  Nucleic Acids Res       Date:  1988-04-25       Impact factor: 16.971

9.  Physicochemical properties of phosphorothioate oligodeoxynucleotides.

Authors:  C A Stein; C Subasinghe; K Shinozuka; J S Cohen
Journal:  Nucleic Acids Res       Date:  1988-04-25       Impact factor: 16.971

10.  Antisense oligonucleotide-directed cleavage of mRNA in Xenopus oocytes and eggs.

Authors:  J Shuttleworth; A Colman
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

View more
  34 in total

1.  Target site search and effective inhibition of leukaemic cell growth by a covalently closed multiple anti-sense oligonucleotide to c-myb.

Authors:  I J Moon; Y Lee; C S Kwak; J H Lee; K Choi; A D Schreiber; J G Park
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

2.  The experimental use of antisense oligonucleotides: a guide for the perplexed.

Authors:  C A Stein
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

3.  Increased specificity for antisense oligodeoxynucleotide targeting of RNA cleavage by RNase H using chimeric methylphosphonodiester/phosphodiester structures.

Authors:  R V Giles; D M Tidd
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

4.  A specific picomolar hybridization-based ELISA assay for the determination of phosphorothioate oligonucleotides in plasma and cellular matrices.

Authors:  Xiaohui Wei; Guowei Dai; Guido Marcucci; Zhongfa Liu; Dale Hoyt; William Blum; Kenneth K Chan
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

Review 5.  Gene modulation for treating liver fibrosis.

Authors:  Kun Cheng; Ram I Mahato
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2007       Impact factor: 4.889

Review 6.  Application of antisense DNA method for the study of molecular bases of brain function and behavior.

Authors:  S Ogawa; D W Pfaff
Journal:  Behav Genet       Date:  1996-05       Impact factor: 2.805

7.  Effects of RNA secondary structure on cellular antisense activity.

Authors:  T A Vickers; J R Wyatt; S M Freier
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

Review 8.  DNA and RNA derivatives to optimize distribution and delivery.

Authors:  Eric Wickstrom
Journal:  Adv Drug Deliv Rev       Date:  2015-04-22       Impact factor: 15.470

9.  Intracellular disposition and metabolism of fluorescently-labeled unmodified and modified oligonucleotides microinjected into mammalian cells.

Authors:  T L Fisher; T Terhorst; X Cao; R W Wagner
Journal:  Nucleic Acids Res       Date:  1993-08-11       Impact factor: 16.971

10.  Effect of antisense TGF-beta1 oligodeoxynucleotides in streptozotocin- induced diabetic rat kidney.

Authors:  Hyo Soon Jeong; Kwan Kyu Park; Kwan Kyu Park; Sang Pyo Kim; In Jang Choi; In Kyu Lee; Hyun Chul Kim
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.